We first investigated the efficacy of glymphatic transport in 14-month-old Tet-Off APP (AD) and control (CTL) mice by assessing the dynamics and distribution patterns of a contrast agent (Gd-DOTA) in the brain. The gene discussed is APP; the disease is Alzheimer disease.